Edwards Lifesciences Corp (EW)

Fixed asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	5,997,700	5,823,000	5,652,900	5,488,400	5,362,000	5,360,300	5,343,800	5,344,000	5,219,100	5,093,000	4,925,300	4,477,100	4,393,400	4,375,800	4,330,900	4,493,400	4,355,200	4,158,800	3,968,100	3,822,500
Property, plant and equipment	US$ in thousands	1,749,400	1,681,300	1,662,200	1,646,000	1,632,800	1,566,400	1,559,900	1,552,200	1,546,600	1,464,600	1,445,800	1,417,900	1,395,200	1,276,300	1,195,600	1,100,600	1,060,300	973,600	931,100	892,200
Fixed asset turnover		3.43	3.46	3.40	3.33	3.28	3.42	3.43	3.44	3.37	3.48	3.41	3.16	3.15	3.43	3.62	4.08	4.11	4.27	4.26	4.28

December 31, 2023 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $5,997,700K ÷ $1,749,400K
= 3.43

Over the past 8 quarters, Edwards Lifesciences Corp has maintained a relatively stable fixed asset turnover ratio, ranging between 3.30 and 3.46. This ratio measures the efficiency of the company in generating revenue from its investment in fixed assets. A higher ratio indicates that the company is generating more sales for each dollar invested in fixed assets.

The consistent range of fixed asset turnover ratios suggests that the company has been effectively utilizing its fixed assets to generate revenue. This stability may be indicative of efficient operations and effective management of its asset base.

Overall, the trend in Edwards Lifesciences Corp's fixed asset turnover ratio indicates a solid performance in terms of utilizing its fixed assets to drive revenue generation over the analyzed period.